Y. Süzer

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice

S. Scheurer, S. Vieths, G. Reese, 2013, Clinical and Translational Allergy.

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.

T. Kuiken, A. Osterhaus, G. Rimmelzwaan, 2010, The Journal of general virology.

Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.

A. Osterhaus, G. Rimmelzwaan, G. van Amerongen, 2008, Veterinary immunology and immunopathology.

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform

H. Eldin, U. Şahin, K. Cichutek, 2015, Journal of Virology.

T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.

B. Moss, A. Osterhaus, G. Sutter, 2006, Viral immunology.